121 related articles for article (PubMed ID: 36535876)
21. Advanced Ann Arbor stage and age over 60 years as prognostic predictors in patients with primary cervical lymphoma: a retrospective cohort study and systematic review.
Gao L; Chen X; Zhao J; Xu A; Liu M; Yu H; Kong S; Li S
BMC Cancer; 2023 Jan; 23(1):95. PubMed ID: 36707772
[TBL] [Abstract][Full Text] [Related]
22. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and survival outcomes of patients with primary intraocular lymphoma: a population-based analysis.
He LF; Zhang JD; Chen XX; Wei RL
BMC Ophthalmol; 2022 Dec; 22(1):486. PubMed ID: 36514001
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Indicators of Survival in Sinonasal Diffuse Large B-Cell Lymphoma: A National Cancer Database Analysis.
Brown HJ; Varelas EA; Ganti A; Papagiannopoulos P; Mark M; Kuan EC; Tajudeen BA
Laryngoscope; 2022 Aug; 132(8):1515-1522. PubMed ID: 34542177
[TBL] [Abstract][Full Text] [Related]
25. Demographic characteristics and prognosis of HHV8-positive diffuse large B-cell lymphoma, not otherwise specified: Insights from a population-based study with a 10-year follow-up.
Wang F; Du Z
Medicine (Baltimore); 2023 Dec; 102(50):e36464. PubMed ID: 38115350
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and clinical survival outcome in patients with primary mediastinal diffuse large B-cell lymphoma in rituximab era: A population-based study.
Hang H; Zhou H; Ma L
Medicine (Baltimore); 2024 Feb; 103(8):e37238. PubMed ID: 38394535
[TBL] [Abstract][Full Text] [Related]
27. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
[No Abstract] [Full Text] [Related]
28. Role of radiation therapy in primary tonsil large B cell lymphoma: a SEER-based analysis.
Jia J; Chen W
Radiat Oncol; 2021 Oct; 16(1):193. PubMed ID: 34600539
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
[TBL] [Abstract][Full Text] [Related]
30. Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL).
Griffiths R; Gleeson M; Knopf K; Danese M
BMC Cancer; 2010 Nov; 10():625. PubMed ID: 21073707
[TBL] [Abstract][Full Text] [Related]
31. Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States.
Shenoy PJ; Malik N; Nooka A; Sinha R; Ward KC; Brawley OW; Lipscomb J; Flowers CR
Cancer; 2011 Jun; 117(11):2530-40. PubMed ID: 24048801
[TBL] [Abstract][Full Text] [Related]
32. Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.
Ballonoff A; Rusthoven KE; Schwer A; McCammon R; Kavanagh B; Bassetti M; Newman F; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1465-71. PubMed ID: 18495371
[TBL] [Abstract][Full Text] [Related]
33. Primary Urinary Tract Lymphoma: Rare but Aggressive.
Lontos K; Tsagianni A; Msaouel P; Appleman LJ; Nasioudis D
Anticancer Res; 2017 Dec; 37(12):6989-6995. PubMed ID: 29187485
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological Features, Treatment, and Prognosis in Primary Diffuse Large B Cell Lymphoma of the Breast: A Retrospective Study of 46 Patients.
Luo H; Yi P; Wang W; Li K; Meng L; Li J; Zeng W; Tang M
Med Sci Monit; 2019 Nov; 25():8671-8682. PubMed ID: 31734687
[TBL] [Abstract][Full Text] [Related]
35. Primary breast diffuse large B-cell lymphoma: a population-based study from 1975 to 2014.
Jia Y; Sun C; Liu Z; Wang W; Zhou X
Oncotarget; 2018 Jan; 9(3):3956-3967. PubMed ID: 29423097
[TBL] [Abstract][Full Text] [Related]
36. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and survival outcomes of primary splenic cancers: A SEER population-based study.
Lei Y; Huang Q; Li X; Zheng X; Liu M
Medicine (Baltimore); 2022 Jan; 101(3):e28539. PubMed ID: 35060511
[TBL] [Abstract][Full Text] [Related]
38. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
[TBL] [Abstract][Full Text] [Related]
39. [Clinical Characteristics of 219 Patients with Primary Gastrointestinal Non-Hodgkin's Lymphoma].
Li YY; Hu DZ; Wang YF; Zhao ZG; Cao Z; Zhang YZ; Zhang HL; Tian C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):849-854. PubMed ID: 32552946
[TBL] [Abstract][Full Text] [Related]
40. [The prognostic impact of diabetic mellitus and hyperglycemia during DLBCL treatment on patients with diffuse large B-cell lymphoma].
Hu Y; Xu YJ; Li MZ; Lan YX; Mao L; Ning QY; Xu W; Yang HL; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2021 Feb; 42(2):151-157. PubMed ID: 33858047
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
